MAPT and early-onset autosomal dominant Alzheimer disease: The use of cell culture–based phenotypic assays can help understand potential mechanistic insights regarding the impact of how a drug works to ameliorate Alzheimer’s disease and related phenotypes such as amyloid-β, neuroinflammation and tau phosphorylation.